P958: REAL-WORLD TREATMENT PATTERNS IN PATIENTS INITIATING THIRD-LINE THERAPY FOR RELAPSED OR REFRACTORY MULTIPLE MYELOMA IN GERMANY, ITALY, THE UK, FRANCE, AND SPAIN
Karthik Ramasamy,
K Martin Kortum,
Evi Zhuleku,
Elena Zamagni,
Tim D’estrube,
Soham Shukla,
Moritz Lehne,
Marco Ghiani,
Maya Hanna,
Ulf Maywald,
Thomas Wilke,
Lenka Kellermann,
Sue Perera
Affiliations
Karthik Ramasamy
1 Oxford University Hospitals, NHS Foundation Trust, Department of Haematology, Freiburg, Germany
K Martin Kortum
2 University Hospital Würzburg, Würzburg, Germany
Evi Zhuleku
3 Cytel Inc, Berlin, Germany
Elena Zamagni
4 Alma Mater Studiorum - Università di Bologna, Bologna, Italy
Tim D’estrube
5 GSK, London, United Kingdom
Soham Shukla
6 GSK, Upper Providence, United States
Moritz Lehne
7 Cytel Inc, Berlin, Germany
Marco Ghiani
8 Institut für Pharmakoökonomie und Arzneimittellogistik, Wismar, Germany
Maya Hanna
9 GSK, Upper Providence, United States
Ulf Maywald
10 AOK PLUS – Projektwerkstatt Dresden, Dresden, Germany
Thomas Wilke
8 Institut für Pharmakoökonomie und Arzneimittellogistik, Wismar, Germany
Lenka Kellermann
11 OncologyInformationService, Freiburg im Breisgau, Germany
